F. Lee

发表

Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer.

H. Scher, J. Chen, F. Sirotnak, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Restoration of Alloreactivity of Melanoma by Transduction With B7.1

M. Brady, J. Latouche, Janet S. Lee, 2000, Journal of immunotherapy.

The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice, with a marked improvement in therapeutic index.

M. Kris, V. Miller, J. Chen, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer

E. Lobenhofer, M. Friedrich, T. Raum, 2020, Clinical Cancer Research.

The serum protein transthyretin as a platform for dimerization and tetramerization of antibodies and Fab fragments to enable target clustering

Zhulun Wang, I. Foltz, K. Walker, 2020, The Journal of Biological Chemistry.

The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD 1839 Selectively Potentiates Radiation Response of Human Tumors in Nude Mice , with a Marked Improvement in Therapeutic Index 1

M. Kris, V. Miller, F. Sirotnak, 2003 .

Mesothelin/CD3 Half-Life–Extended Bispecific T-Cell Engager Molecule Shows Specific Tumor Uptake and Distributes to Mesothelin and CD3-Expressing Tissues

E. D. de Vries, M. Friedrich, B. van der Vegt, 2021, The Journal of Nuclear Medicine.

Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII

M. Friedrich, M. Muenz, B. Rattel, 2021, Molecular Cancer Therapeutics.

Structure of the Nuclear Factor κB-inducing Kinase (NIK) Kinase Domain Reveals a Constitutively Active Conformation

N. Walker, Z. Cao, O. Plotnikova, 2012, The Journal of Biological Chemistry.

Inhibiting NF-κB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures.

O. Plotnikova, Zhulun Wang, Jinsong Liu, 2013, Bioorganic & medicinal chemistry letters.

CD4+ T cells kill HLA-class-II-antigen-positive melanoma cells presenting peptide in vitro

H. Petrie, M. Brady, David D. Eckels, 2000, Cancer Immunology, Immunotherapy.

Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme

Dean Wu, Chaur-Jong Hu, Shengxing Lu, 2019 .

Immunotherapeutic targeting and PET imaging of DLL3 in small cell neuroendocrine prostate cancer.

Yuzhuo Wang, F. Feng, E. Small, 2022, Cancer Research.